Hebei Senlang Biotechnology Inc., Ltd.

Guangzhou

OncologyCAR-TPhase III

Compare Sign in to watch

What changed

Phase III trial registered: SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

2w agoTrial registeredJul 1, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

675 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
PHASE2 registered
Jun 1, 2026
CRC, Liver Metastasis Colon Cancer · NOT_YET_RECRUITING · sponsor: Jun Huang · Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
ClinicalTrials.gov · NCT07381309 (opens the source filing in a new tab)
Trial
PHASE3 registered
May 20, 2026
Rectal Adenocarcinoma, High-Risk Cancer, MSS · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
ClinicalTrials.gov · NCT07549399 (opens the source filing in a new tab)
Trial
EARLY_PHASE1 registered
Feb 4, 2026
UC · RECRUITING · sponsor: Hebei Senlang Biotechnology Inc., Ltd. · Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
ClinicalTrials.gov · NCT07435779 (opens the source filing in a new tab)
Trial
PHASE3 registered
Apr 10, 2025
Colorectal Cancer, Liver Metastases · RECRUITING · sponsor: Jun Huang · SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
ClinicalTrials.gov · NCT06794086 (opens the source filing in a new tab)
Trial
PHASE2 registered
Apr 2, 2025
Rectal Adenocarcinoma, High-Risk Cancer, MSS · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)
ClinicalTrials.gov · NCT06908031 (opens the source filing in a new tab)
Trial
PHASE3 registered
Jan 18, 2025
Colorectal Cancer (CRC), pMMR/MSS Adenocarcinoma of the Colon or Rectum · RECRUITING · sponsor: Jun Huang · mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
ClinicalTrials.gov · NCT06791512 (opens the source filing in a new tab)
Trial
PHASE2 registered
Jan 6, 2025
Unresectable Locally Recurrent Rectal Cancer · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
ClinicalTrials.gov · NCT06767007 (opens the source filing in a new tab)
Trial
PHASE2 registered
Apr 12, 2024
Rectal Squamous Cell Carcinoma · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
ClinicalTrials.gov · NCT06364384 (opens the source filing in a new tab)
Trial
NA registered
Sep 1, 2023
Colorectal Neoplasm · ACTIVE_NOT_RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer
ClinicalTrials.gov · NCT05953662 (opens the source filing in a new tab)
Trial
NA registered
Aug 8, 2023
Rectal Neoplasms, Low Anterior Resection Syndrome, Anastomotic Leak, Quality of Life · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
ClinicalTrials.gov · NCT05943444 (opens the source filing in a new tab)
Trial
Study registered
Apr 18, 2022
Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease · RECRUITING · sponsor: The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine · Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
ClinicalTrials.gov · NCT06833541 (opens the source filing in a new tab)
Trial
NA registered
Jan 1, 2021
Rectal Cancer · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
ClinicalTrials.gov · NCT04643041 (opens the source filing in a new tab)
Trial
NA registered
Apr 30, 2019
Colorectal Cancer, Adjuvant Chemotherapy · RECRUITING · sponsor: Sixth Affiliated Hospital, Sun Yat-sen University · Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis
ClinicalTrials.gov · NCT03748485 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 73%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Phase III trial registered: SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
2w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
2w agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)
2w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT)
2w agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
2w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
2w agoTrial recruitingSource (opens the source filing in a new tab)
Phase III trial registered: SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
3w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases
3w agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis
6w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Adjuvant Chemotherapy in Clinical Local Advanced CRC Following Preoperational Therapies and pT0-3N0M0 Diagnosis
6w agoTrial recruitingSource (opens the source filing in a new tab)
Phase II trial registered: Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM
2mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Safety and Efficacy of Reduced-port Laparoscopic Surgery for Patients Of Colon and Upper Rectal Cancer
2mo agoTrial registeredSource (opens the source filing in a new tab)
Phase II trial registered: SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
2mo agoTrial recruitingSource (opens the source filing in a new tab)
Phase I trial registered: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
4mo agoTrial recruitingSource (opens the source filing in a new tab)
Phase III trial registered: mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
6mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC
6mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
7mo agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
7mo agoTrial recruitingSource (opens the source filing in a new tab)
Study registered, no phase assigned: Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
Feb 2025Trial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
Feb 2025Trial recruitingSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Peer position

Grant to raise

PHASE2 registered

PHASE3 registered

EARLY_PHASE1 registered

PHASE3 registered

PHASE2 registered

PHASE3 registered

PHASE2 registered

PHASE2 registered

NA registered

NA registered

Study registered

NA registered

NA registered